On September 2, 2020 Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) reported that the share buy-back program, which was announced and initiated on August 26, 2020, has now been terminated, as the intended number of shares under the program has been repurchased (Press release, Bavarian Nordic, SEP 2, 2020, View Source [SID1234564328]). The program was executed in accordance with the provisions of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and supplementing Regulation (EU) 2016/1052 of 8 March 2016, which together constitute the Safe Harbour Regulation. The purpose of the program was to meet the Company’s obligations arising from the share-based incentive program for the Board of Directors and Executive Management.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Under the program Bavarian Nordic A/S has bought back 52,397 shares, cf. the table below:
Transaction date Number of shares Average purchase price, DKK Transaction Value, DKK
August 26, 2020 4,000 199.89 799,544
August 27, 2020 7,000 209.87 1,469,090
August 28, 2020 12,000 210.62 2,527,440
August 31, 2020 7,000 218.64 1,530,480
September 1, 2020 10,000 216.11 2,161,100
September 2, 2020 12,397 210.22 2,606,097
Accumulated under the program 52,397 211.72 11,093,751
The details for each transaction made under the share repurchase program have been attached to this announcement.
With the transactions stated above, Bavarian Nordic A/S owns a total of 107,646 own shares, corresponding to 0.18% of the share capital. The total amount of shares in the company is 58,450,112 including treasury shares.